The French retail bank will buy the Portuguese lender from its majority owner Lone Star in the latest cross-border deal in European banking. A chip-manufacturing spinoff could help solve some of the ...

23andMe struck a deal last month with Regeneron Pharmaceuticals Inc., but Wojcicki complained about the bidding process, ...

UnitedHealth Group ( UNH -1.61%) was the worst-performing stock in the S&P 500 last month. It plunged 26.6% to 52-week lows of $248.88 per share on May 15 after CEO Andrew Witty abruptly resigned and ...

The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.

Several states have joined a lawsuit against 23andme. They say bankruptcy shouldn't allow the genetic testing company to sell ...

Welcome to the future, folks—where AI is regulated, genetic testing companies have more plot twists than a soap opera, and ...

Texas Attorney General Ken Paxton is looking to protect Texans' genetic data with action filed this week in ongoing 23andMe ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

A.I. may push ad creatives from producing to consulting. At Cannes, Monks, a marketing technology agency, will showcase a new ...

Anne Wojcicki, the co-founder and former CEO of 23andMe, will purchase the bankrupt company’s assets for $305 million, the genetic testing company said Friday. Regeneron Pharmaceuticals had agreed to ...

Me, which became a household name for its genetic testing services, is set to emerge from bankruptcy as a nonprofit.

Me could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.